Literature DB >> 36241752

Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.

Linda C Chu1, Zhen J Wang2, Avinash Kambadakone3, Elizabeth M Hecht4, Jin He5, Amol K Narang6, Daniel A Laheru7, Hina Arif-Tiwari8, Priya Bhosale9, Candice W Bolan10, Olga R Brook11, Abraham F Bezuidenhout11, Richard K G Do12, Samuel J Galgano13, Ajit H Goenka14, Alexander R Guimaraes15, David M Hough14, Naveen Kulkarni16, Ott Le9, Lyndon Luk17, Lorenzo Mannelli18, Michael Rosenthal19, Guillermo Sangster20, Zarine K Shah21, Erik V Soloff22, Parag P Tolat16, Marc Zins23, Elliot K Fishman24, Eric P Tamm9, Atif Zaheer24.   

Abstract

PURPOSE: Surgical resection is the only potential curative treatment for patients with pancreatic ductal adenocarcinoma (PDAC), but unfortunately most patients recur within 5 years of surgery. This article aims to assess the practice patterns across major academic institutions and develop consensus recommendations for postoperative imaging and interpretation in patients with PDAC.
METHODS: The consensus recommendations for postoperative imaging surveillance following PDAC resection were developed using the Delphi method. Members of the Society of Abdominal Radiology (SAR) PDAC Disease Focused Panel (DFP) underwent three rounds of surveys followed by live webinar group discussions to develop consensus recommendations.
RESULTS: Significant variations currently exist in the postoperative surveillance of PDAC, even among academic institutions. Differentiating common postoperative inflammatory and fibrotic changes from tumor recurrence remains a diagnostic challenge, and there is no reliable size threshold or growth rate of imaging findings that can provide differentiation. A new liver lesion or peritoneal nodule should be considered suspicious for tumor recurrence, and the imaging features should be interpreted in the appropriate clinical context (e.g., CA 19-9, clinical presentation, pathologic staging).
CONCLUSION: Postoperative imaging following PDAC resection is challenging to interpret due to the presence of confounding postoperative inflammatory changes. A standardized reporting template for locoregional findings and report impression may improve communication of relaying risk of recurrence with referring providers, which merits validation in future studies.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CT; MRI; Pancreatic ductal adenocarcinoma; Recurrence

Year:  2022        PMID: 36241752     DOI: 10.1007/s00261-022-03693-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  33 in total

1.  CT diagnosis of recurrence after pancreatic cancer: is there a pattern?

Authors:  Tobias Heye; Nicola Zausig; Miriam Klauss; Reinhard Singer; Jens Werner; Götz Martin Richter; Hans-Ulrich Kauczor; Lars Grenacher
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

2.  Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial.

Authors:  Robert P Jones; Eftychia-Eirini Psarelli; Richard Jackson; Paula Ghaneh; Christopher M Halloran; Daniel H Palmer; Fiona Campbell; Juan W Valle; Olusola Faluyi; Derek A O'Reilly; David Cunningham; Jonathan Wadsley; Suzanne Darby; Tim Meyer; Roopinder Gillmore; Alan Anthoney; Pehr Lind; Bengt Glimelius; Stephen Falk; Jakob R Izbicki; Gary William Middleton; Sebastian Cummins; Paul J Ross; Harpreet Wasan; Alec McDonald; Tom Crosby; Yuk Ting; Kinnari Patel; David Sherriff; Rubin Soomal; David Borg; Sharmila Sothi; Pascal Hammel; Markus M Lerch; Julia Mayerle; Christine Tjaden; Oliver Strobel; Thilo Hackert; Markus W Büchler; John P Neoptolemos
Journal:  JAMA Surg       Date:  2019-11-01       Impact factor: 14.766

3.  Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.

Authors:  Vincent P Groot; Neda Rezaee; Wenchuan Wu; John L Cameron; Elliot K Fishman; Ralph H Hruban; Matthew J Weiss; Lei Zheng; Christopher L Wolfgang; Jin He
Journal:  Ann Surg       Date:  2018-05       Impact factor: 12.969

4.  Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma.

Authors:  Akhil Chawla; Motaz Qadan; Carlos Fernandez-Del Castillo; Jennifer Y Wo; Jill N Allen; Jeffrey W Clark; Janet E Murphy; Onofrio A Catalano; David P Ryan; David T Ting; Vikram Deshpande; Colin D Weekes; Aparna Parikh; Keith D Lillemoe; Theodore S Hong; Cristina R Ferrone
Journal:  Ann Surg       Date:  2020-10-19       Impact factor: 13.787

Review 5.  Therapeutic response assessment in pancreatic ductal adenocarcinoma: society of abdominal radiology review paper on the role of morphological and functional imaging techniques.

Authors:  Zhen J Wang; Hina Arif-Tiwari; Atif Zaheer; Sanaz Ameli; Priya R Bhosale; Richard K Do; Ajit H Goenka; Alexander R Guimares; Guillermo P Sangster; Erik V Soloff; Eric P Tamm; Marc Zins; Avinash R Kambadakone
Journal:  Abdom Radiol (NY)       Date:  2020-09-16

6.  The Time to and Type of Pancreatic Cancer Recurrence after Surgical Resection: Is Prediction Possible?

Authors:  Jelena Djokić Kovač; Philipp Mayer; Thilo Hackert; Miriam Klauss
Journal:  Acad Radiol       Date:  2018-09-22       Impact factor: 3.173

7.  Defining and Predicting Early Recurrence in 957 Patients With Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Vincent P Groot; Georgios Gemenetzis; Alex B Blair; Roberto J Rivero-Soto; Jun Yu; Ammar A Javed; Richard A Burkhart; Inne H M Borel Rinkes; I Quintus Molenaar; John L Cameron; Matthew J Weiss; Christopher L Wolfgang; Jin He
Journal:  Ann Surg       Date:  2019-06       Impact factor: 13.787

8.  Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.

Authors:  Mark J Truty; Michael L Kendrick; David M Nagorney; Rory L Smoot; Sean P Cleary; Rondell P Graham; Ajit H Goenka; Christopher L Hallemeier; Michel G Haddock; William S Harmsen; Amit Mahipal; Robert R McWilliams; Thorvardur R Halfdanarson; Axel F Grothey
Journal:  Ann Surg       Date:  2021-02-01       Impact factor: 13.787

9.  Recurrence patterns and postrecurrence survival after curative intent resection for pancreatic ductal adenocarcinoma.

Authors:  Hordur Kolbeinsson; Allison Hoppe; Aqieda Bayat; Benjamin Kogelschatz; Chineze Mbanugo; Mathew Chung; Andrea Wolf; M Mura Assifi; G Paul Wright
Journal:  Surgery       Date:  2020-08-15       Impact factor: 3.982

10.  Timing But Not Patterns of Recurrence Is Different Between Node-negative and Node-positive Resected Pancreatic Cancer.

Authors:  Kim C Honselmann; Ilaria Pergolini; Carlos Fernandez-Del Castillo; Vikram Deshpande; David Ting; Martin S Taylor; Louisa Bolm; Motaz Qadan; Ulrich Wellner; Marta Sandini; Dirk Bausch; Andrew L Warshaw; Keith D Lillemoe; Tobias Keck; Cristina R Ferrone
Journal:  Ann Surg       Date:  2020-08       Impact factor: 13.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.